The Design of Leadlike Combinatorial Libraries

Simon J. Teague(AstraZeneca (United Kingdom)), A. M. Davis(AstraZeneca (United Kingdom)), Paul D. Leeson(AstraZeneca (United Kingdom)), Tudor I. Oprea(Loughborough University)
Angewandte Chemie International Edition
December 16, 1999
Cited by 808

Abstract

The optimization of low-potency leads into drugs is often accompanied by an increase in molecular weight (M(r)) and lipophilicity, as a consequence of affinity enhancement. Hits with affinity at µM levels discovered by screening leadlike libraries allow scope for this optimization process, as shown schematically by the distributions of M(r) for a leadlike library (1), oral drugs (2), and a typical combinatorial chemistry library (3). y=percentage with a particular molecular weight.


Related Papers

No related papers found

Powered by citation graph analysis